French Open Will Allow Wearables Like Whoop on ‘Trial Basis’

Why It Matters

The policy shift opens the door for data‑driven performance monitoring at tennis’s biggest stages, creating new revenue streams for tech firms and potentially reshaping athlete preparation.

Key Takeaways

• French Open permits Whoop wearables on trial, first Grand Slam approval
• Trial will also cover Wimbledon and US Open later this year
• Players previously forced to remove devices at Australian Open
• ITF already approves wearables; Grand Slam rules were the barrier
• Data-driven wearables could become standard for elite tennis performance

Pulse Analysis

The tennis world has long been divided over the use of biometric wearables on court. While the International Tennis Federation cleared devices such as Whoop for ATP and WTA tour events in 2024, the four Grand Slam tournaments maintained a separate rulebook that prohibited any on‑court data collection. At the 2026 Australian Open, high‑profile players including Carlos Alcaraz, Jannik Sinner and Aryna Sabalenka were instructed to remove their Whoop bands, sparking public criticism and a social‑media outcry. The French Open’s decision to lift the ban on a trial basis therefore represents a watershed moment in reconciling tour‑level technology with the sport’s most prestigious stages.

Allowing wearables promises tangible benefits for athletes. Real‑time heart‑rate, sleep quality and recovery metrics enable players and coaches to fine‑tune training cycles, manage fatigue, and make informed tactical adjustments during a two‑week slam. For technology firms, Grand Slam exposure translates into premium branding opportunities and direct access to a global fan base, potentially accelerating investment in sports‑tech startups. The move also aligns with broader trends in professional leagues that are embracing data analytics to enhance performance, injury prevention, and fan engagement through richer broadcast graphics.

Looking ahead, the trial could set a precedent that standardizes wearable use across all four majors. If the French Open, Wimbledon and the US Open report positive feedback from players and officials, the ATP and WTA may push for a unified Grand Slam policy, reducing regulatory fragmentation. Critics worry about competitive equity, but proponents argue that non‑invasive data is akin to a personal coach rather than a performance enhancer. Ultimately, the integration of wearables may reshape how elite tennis is prepared, played, and consumed, cementing data‑driven insights as a core component of the sport’s evolution.